Literature DB >> 14679140

Renal tubular damage in rasburicase: risks of alkalinisation.

H van den Berg, A M Reintsema.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 14679140     DOI： 10.1093/annonc/mdh029

Source DB:  PubMed          Journal:  Ann Oncol        ISSN： 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  8 in total

1.  Spontaneous tumour lysis syndrome secondary to the transformation of chronic myelomonocytic leukaemia into acute myeloid leukaemia.

Authors:  Alexander Langridge; Kathryn Musgrave; Yogesh Upadhye
Journal:  BMJ Case Rep       Date:  2016-03-09

Review 2.  [Acute renal failure].

Authors:  M Krych
Journal:  Internist (Berl)       Date:  2005-01       Impact factor: 0.743

Review 3.  Serum uric acid-lowering therapies: where are we heading in management of hyperuricemia and the potential role of uricase.

Authors:  John S Bomalaski; Mike A Clark
Journal:  Curr Rheumatol Rep       Date:  2004-06       Impact factor: 4.592

Review 4.  Recognizing and managing the expanded risk of tumor lysis syndrome in hematologic and solid malignancies.

Authors:  Ali McBride; Peter Westervelt
Journal:  J Hematol Oncol       Date:  2012-12-13       Impact factor: 17.388

5.  Emerging role of rasburicase in the management of increased plasma uric acid levels in patients with hematologic malignancies.

Authors:  Leanne D Kennedy; Susannah Koontz; Kamakshi Rao
Journal:  J Blood Med       Date:  2011-02-04

6.  Serum phosphate level and its kinetic as an early marker of acute kidney injury in tumor lysis syndrome.

Authors:  Marie Lemerle; Aline Schmidt; Valérie Thepot-Seegers; Achille Kouatchet; Valérie Moal; Melina Raimbault; Corentin Orvain; Jean-François Augusto; Julien Demiselle
Journal:  J Nephrol       Date:  2022-02-02       Impact factor: 4.393

Review 7.  Tumor lysis syndrome in childhood malignancies.

Authors:  Wing Lum Cheung; Kam Lun Hon; Cheuk Man Fung; Alexander Kc Leung
Journal:  Drugs Context       Date:  2020-02-25

8.  Evaluation of the safety and efficacy of low-dose rasburicase in critically ill children with haematological malignancies.

Authors:  Yuxin Pei; Yu Li; Yujian Liang; Lingling Xu; Xueqiong Huang; Yijuan Li; Wen Tang; Xiaoyun Jiang
Journal:  Int J Clin Pharm       Date:  2020-09-24
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.